Home › Funds › Squadron Capital Management LLC › COGT

Squadron Capital Management LLC position in COGT

COGENT BIOSCIENCES INC · Health Care

Squadron Capital Management LLC reported holding 265,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 3.36% of its reported portfolio and ranking #12 among its reported holdings. Squadron Capital Management LLC has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)265.00K sh
Reported value held$8.49M
Portfolio Weight3.36%
First reportedQ4 2025
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Squadron Capital Management LLC's COGT position evolved

Squadron Capital Management LLC first disclosed a stake in COGT in Q4 2025 at 780,000 shares (US$27.7M). The position peaked in Q2 2026 at 865,000 shares, worth US$33.5M. Across 4 filings, Squadron Capital Management LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 265,000 shares valued at US$8.5M — a reduction of -600,000 shares quarter over quarter.. Notable position changes include a 69% trim in Q3 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 780.00K $27.71M New
Q1 2026 787.49K $30.31M Add
Q2 2026 865.00K $33.48M Add
Q3 2026 265.00K $8.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 51 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Squadron Capital Management LLC held COGT?

Squadron Capital Management LLC has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Squadron Capital Management LLC's current position in COGT?

As of Q3 2026, Squadron Capital Management LLC holds 265.00K shares of COGT (COGENT BIOSCIENCES INC), valued at $8.49M, representing 3.36% of its reported portfolio and ranking #12.

Has Squadron Capital Management LLC been buying or selling COGT?

In the latest 13F filing (Q3 2026), Squadron Capital Management LLC reduced its position in COGT. The position peaked in Q2 2026 at 865.00K shares.

Which other funds hold COGT?

Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.